BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 19733826)

  • 21. Inhaled insulin: new technology, new possibilities.
    Bellary S; Barnett AH
    Int J Clin Pract; 2006 Jun; 60(6):728-34. PubMed ID: 16805759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Willingness to pay for voluntary community-based health insurance: findings from an exploratory study in the state of Penang, Malaysia.
    Shafie AA; Hassali MA
    Soc Sci Med; 2013 Nov; 96():272-6. PubMed ID: 23528670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unlocking the opportunity of tight glycaemic control. Promise ahead: the role of inhaled insulin in clinical practice.
    Heine RJ
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S19-23. PubMed ID: 16135135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preference for insulin delivery systems among current insulin users and nonusers.
    Summers KH; Szeinbach SL; Lenox SM
    Clin Ther; 2004 Sep; 26(9):1498-505. PubMed ID: 15531012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Willingness to pay for cataract surgery in rural Southern China.
    He M; Chan V; Baruwa E; Gilbert D; Frick KD; Congdon N
    Ophthalmology; 2007 Mar; 114(3):411-6. PubMed ID: 17197026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perception of the economic value of primary care services: a Willingness to Pay study.
    Martín-Fernández J; Gómez-Gascón T; Oliva-Moreno J; del Cura-González MI; Domínguez-Bidagor J; Beamud-Lagos M; Sanz-Cuesta T
    Health Policy; 2010 Mar; 94(3):266-72. PubMed ID: 19945763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment satisfaction of diabetic patients: what are the contributing factors?
    Biderman A; Noff E; Harris SB; Friedman N; Levy A
    Fam Pract; 2009 Apr; 26(2):102-8. PubMed ID: 19254969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of patients with diabetes mellitus by means of inhaled insulin].
    Simsek S; de Galan BE; Tack CJ; Heine RJ
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):829-32. PubMed ID: 16676511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy.
    Scherbaum WA
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy.
    Petersen KD; Gyrd-Hansen D; Linneberg A; Dahl R; Larsen JN; Løwenstein H; Kronborg C
    Int J Technol Assess Health Care; 2010 Jan; 26(1):20-9. PubMed ID: 20059777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus.
    de Galan BE; Simsek S; Tack CJ; Heine RJ
    Neth J Med; 2006 Oct; 64(9):319-25. PubMed ID: 17057268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient perceptions of insulin detemir as reported through patient telephone surveys.
    Kerney DL; Paradis D; Brunton S
    Curr Med Res Opin; 2007 Sep; 23(9):2043-9. PubMed ID: 17640448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Willingness to pay for health insurance: an analysis of the potential market for new low-cost health insurance products in Namibia.
    Gustafsson-Wright E; Asfaw A; van der Gaag J
    Soc Sci Med; 2009 Nov; 69(9):1351-9. PubMed ID: 19765877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Willingness to pay for zinc treatment of childhood diarrhoea in a rural population of Bangladesh.
    Akhter S; Larson CP
    Health Policy Plan; 2010 May; 25(3):230-6. PubMed ID: 19955094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An assessment of the burden of migraine using the willingness to pay model.
    Hamelsky SW; Lipton RB; Stewart WF
    Cephalalgia; 2005 Feb; 25(2):87-100. PubMed ID: 15658945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicians' perceptions towards the impact of and willingness to pay for clinical computerization in Hong Kong.
    Leung GM; Yeung RY; Lai TY; Johnston JM; Tin KY; Wong IO; Woo PP; Ho LM
    Int J Med Inform; 2004 Jun; 73(5):403-14. PubMed ID: 15171982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluation of insulin lispro versus neutral (regular) insulin therapy using a willingness-to-pay approach.
    Davey P; Grainger D; MacMillan J; Rajan N; Aristides M; Dobson M
    Pharmacoeconomics; 1998 Mar; 13(3):347-58. PubMed ID: 10178660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Willingness to pay for praziquantel treatment in a hyperendemic community of Ogun State, Nigeria.
    Adeneye AK; Mafe MA; Appelt B; Idowu ET; Akande DO
    Res Social Adm Pharm; 2006 Mar; 2(1):83-95. PubMed ID: 17138502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of inhaled insulin.
    Mastrandrea LD; Quattrin T
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1061-75. PubMed ID: 17070613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.